Company / Cost of Revenue
Enveric Biosciences, Inc. Cost of Revenue History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$34.0M
FY2019
5-year range
$29.2M / $38.4M
FY2017-FY2019
Trend
-11.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $29M to $34M over the past 2 years.
Based on SEC 10-K filings.
$34M in FY2019.
Increased from $29M to $34M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cost of revenue decreased 11.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $34.0M | -11.3% |
| FY2018 | $38.4M | +31.3% |
| FY2017 | $29.2M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026